Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: a randomized controlled trial
Open Access
- 1 October 2019
- journal article
- research article
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 72 (5) , 479-485
Abstract
Background: Ultrasound-guided greater occipital nerve (GON) block has been frequently used to treat various types of headaches, and botulinum toxin has recently begun to be used in patients with headache. Our study presents the longterm effect of botulinum toxin on GON block using ultrasound in patients with chronic headache in occipital area. Methods: Patients with occipital headache were divided into two groups (bupivacaine: BUP group [n = 27], botulinum toxin: BTX group [n = 27]), and ultrasound-guided GON block was performed at the C2 level. GON was detected with ultrasound and distance from GON to midline, from the skin surface to GON, and size of GON were measured in both groups. Visual analogue scale (VAS) scores and Likert scale were assessed at pretreatment and at 1, 4, 8, and 24 weeks after treatment in both groups. Results: The distance from GON to midline was 18.9 ± 4.4 mm (right) and 17.3 ± 3.8 mm (left). The depth from the skin was 12.9 ± 1.5 mm (right) and 13.4 ± 1.6 mm (left). GON size was 3.1 mm on both sides. The VAS score and patient satisfaction score (Likert scale) in 4, 8, and 24 weeks after injection were superior for the BTX than the BUP group. Conclusions: Ultrasound-guided GON block using BTX is effective in reducing short-term and long-term pain in patients with chronic headache in the occipital area.Keywords
Funding Information
- Hanyang University
This publication has 31 references indexed in Scilit:
- Occipital neuralgia: Anatomic considerationsClinical Anatomy, 2014
- Sonographic visualization and ultrasound-guided blockade of the greater occipital nerve: a comparison of two selective techniques confirmed by anatomical dissectionBritish Journal of Anaesthesia, 2010
- Botulinum toxin A for myofascial trigger point injection: A qualitative systematic reviewEuropean journal of pain, 2007
- Greater occipital nerve injection in primary headache syndromes – prolonged effects from a single injectionPain, 2006
- Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover studyPain, 2005
- Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: A double-blind placebo-controlled studyPain, 2005
- The course of the greater occipital nerve in the suboccipital region: A proposal for setting landmarks for local anesthesia in patients with occipital neuralgiaClinical Anatomy, 2005
- Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic casesJournal of the American Academy of Dermatology, 2005
- Botulinal neurotoxins: revival of an old killerCurrent Opinion in Pharmacology, 2005
- Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label studyOtolaryngology–Head and Neck Surgery, 2000